The Elderly ACS II Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1457 participants.
Also called NCT01777503
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,457 participants
- Registry
-
NCT01777503
-
- Other papers using this trial's data
- Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization
- Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01777503. Randomized; single masking; primary purpose treatment. Start 2012-11 (actual); primary completion 2017-01-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Elderly ACS II Trial
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Arteriosclerosis
- Condition
- Myocardial Ischemia
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- prasugrel
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Azienda USL Reggio Emilia - IRCCS
- Collaborator
- ANMCO Italian Association of Hospital Cardiologist
- Collaborator
- Italian Society of Invasive Cardiology
- Collaborator
- A. Manzoni Hospital
Record details
- Record id
cardio:ct-nct01777503- Content hash
673792e81257659ed1451024184795ed14aa478383a49190be728ada06258033